Abstract
BackgroundRecent reports revealed that CD8+ T cell antitumor responses rely on a subset of stem-like CD8+ T cells during cancer immunity and immunotherapy. However, the origin of stem-like CD8+ T...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
